Gregory R Bluemling

Publication Activity (10 Years)

Years Active: 2020-2021
Publications (10 Years): 4

Top Topics

Pluripotent Stem Cells

Respiratory Syncytial Virus

Top Venues

Science translational medicine

Science (New York, N.Y.)

This page only lists publications with an associated author ORCID identifier.

Publications

Julien Sourimant, Carolin M Lieber, Megha Aggarwal, Robert M Cox, Josef D Wolf, Jeong-Joong Yoon, Mart Toots, Chengjin Ye, Zachary M Sticher, Alexander A Kolykhalov, Luis Martinez-Sobrido, Gregory R Bluemling, Michael G Natchus, George R Painter, Richard K Plemper
4'-Fluorouridine is an oral antiviral that blocks respiratory syncytial virus and SARS-CoV-2 replication. Science (New York, N.Y.) (2021)
Angela Wahl, Lisa E Gralinski, Claire E Johnson, Wenbo Yao, Martina Kovarova, Kenneth H Dinnon Iii, Hongwei Liu, Victoria J Madden, Halina M Krzystek, Chandrav De, Kristen K White, Kendra L Gully, Alexandra Schäfer, Tanzila Zaman, Sarah R Leist, Paul O Grant, Gregory R Bluemling, Alexander A Kolykhalov, Michael G Natchus, Frederic B Askin, George Painter, Edward P Browne, Corbin D Jones, Raymond J Pickles, Ralph S Baric, J Victor Garcia-Martinez
SARS-CoV-2 infection is effectively treated and prevented by EIDD-2801. Nature 591 (7850) (2021)
Mart Toots, Jeong-Joong Yoon, Robert M Cox, Michael Hart, Zachary M Sticher, Negar Makhsous, Roland Plesker, Alec H Barrena, Prabhakar G Reddy, Deborah G Mitchell, Ryan C Shean, Gregory R Bluemling, Alexander A Kolykhalov, Alexander L Greninger, Michael G Natchus, George R Painter, Richard K Plemper
Characterization of orally efficacious influenza drug with high resistance barrier in ferrets and human airway epithelia. Science translational medicine 11 (515) (2020)
Timothy P Sheahan, Amy C Sims, Shuntai Zhou, Rachel L Graham, Andrea J Pruijssers, Maria L Agostini, Sarah R Leist, Alexandra Schaefer, Kenneth H Dinnon Iii, Laura J Stevens, James D Chappell, Xiaotao Lu, Tia M Hughes, Amelia S George, Collin S Hill, Stephanie A Montgomery, Ariane J Brown, Gregory R Bluemling, Michael G Natchus, Manohar Saindane, Alexander A Kolykhalov, George R Painter, Jennifer L Harcourt, Azaibi Tamin, Natalie J Thornburg, Ronald Swanstrom, Mark R Denison, Ralph S Baric
An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice. Science translational medicine 12 (541) (2020)